World's Best Scientists 2026 revealed!
Ingo G.H. Schmidt-Wolf

Ingo G.H. Schmidt-Wolf

D-Index & Metrics

Medicine

D-Index
78
Citations
27283
World Ranking
17894
National Ranking
940

Overview

Ingo G.H. Schmidt-Wolf is affiliated with the University Hospital Bonn in Germany. Their research spans multiple areas within medicine, particularly focusing on oncology, molecular biology, and immunology. Their work is also connected with cancer research and pulmonary and respiratory medicine as significant subfields of their study.

The scientist has contributed extensively to the understanding of immune cell function and interaction, CAR-T cell therapy research, and cancer immunotherapy and biomarkers. Other main topics in their research include cancer-related molecular mechanisms, histone deacetylase inhibitors, immunotherapy and immune responses, and extracellular vesicles in disease.

Frequent co-authors in Schmidt-Wolf's research include Amit Sharma, Miroslaw Kornek, Maria A. González-Carmona, Yulu Wang, and Christian P. Strassburg.

Their publications often appear in reputable journals, with repeated contributions in venues such as:

  • Cancers
  • Frontiers in Immunology
  • Cancer Immunology Immunotherapy
  • Frontiers in Oncology
  • Scientific Reports

Selected recent papers include:

  • Ten-year update of the international registry on cytokine-induced killer cells in cancer immunotherapy, 2020, Journal of Cellular Physiology
  • Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome, 2020, BMC Cancer
  • Oncogenes and tumor suppressor genes: functions and roles in cancers, 2024, MedComm
  • 30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective, 2021, Journal of Experimental & Clinical Cancer Research
  • Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives, 2024, Experimental Hematology and Oncology

The main fields of study where Schmidt-Wolf has published include Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Their multidisciplinary approach combines expertise in oncology and molecular biology with a strong focus on immune mechanisms relevant to cancer therapy.

Best Publications

  • Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

    Gary Hudes;Michael Carducci;Piotr Tomczak;Janice Dutcher

  • Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

    Helmut Oettle;Stefan Post;Peter Neuhaus;Klaus Gellert

  • Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

    Pieter Sonneveld;Ingo G.H. Schmidt-Wolf;Bronno Van Der Holt;Laila El Jarari

  • Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

    Hendrik Pels;Ingo G.H. Schmidt-Wolf;Axel Glasmacher;Holger Schulz

  • Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study

    Anjali Advani;Bertrand Coiffier;Myron S. Czuczman;Martin Dreyling

  • Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

    Kai Neben;Henk M. Lokhorst;Anna Jauch;Uta Bertsch

  • RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group

    Verena I. Gaidzik;Lars Bullinger;Richard F. Schlenk;Andreas S. Zimmermann

  • Itraconazole Prevents Invasive Fungal Infections in Neutropenic Patients Treated for Hematologic Malignancies: Evidence From a Meta-Analysis of 3,597 Patients

    Axel Glasmacher;Archibald Prentice;Marcus Gorschlüter;Steffen Engelhart

  • Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial.

    Angela Märten;Dimitri Flieger;Sabine Renoth;Silvia Weineck

  • Non-viral and hybrid vectors in human gene therapy: an update

    Gabriele D Schmidt-Wolf;Ingo G.H Schmidt-Wolf

  • High EVI1 Expression Predicts Outcome in Younger Adult Patients With Acute Myeloid Leukemia and Is Associated With Distinct Cytogenetic Abnormalities

    Stefan Gröschel;Sanne Lugthart;Richard F. Schlenk;Peter J.M. Valk

  • A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma.

    Axel Glasmacher;Corinna Hahn;Florian Hoffmann;Ralph Naumann

  • Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations.

    Märten A;Ziske C;Schöttker B;Renoth S

  • Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

    Dieter Hoelzer;Jan Walewski;Hartmut Döhner;Andreas Viardot

  • Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial.

    Burghardt Wittig;Angela Märten;Tomislav Dorbic;Silvia Weineck

  • Clinical Trials on CIK Cells: First Report of the International Registry on CIK Cells (IRCC)

    C. Hontscha;Y. Borck;H. Zhou;D. Messmer

  • Neutropenic enterocolitis in adults: systematic analysis of evidence quality.

    Marcus Gorschlüter;Ulrich Mey;John Strehl;Carsten Ziske

  • Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

    C Ziske;C Schlie;M Gorschlüter;A Glasmacher

  • Mechanism of Cytotoxicity Induced by Chimeric Mouse Human Monoclonal Antibody IDEC-C2B8 in CD20-Expressing Lymphoma Cell Lines

    Dimitri Flieger;Sabine Renoth;Imke Beier;Tilman Sauerbruch

  • Repeated Bone-Targeted Therapy for Hormone-Refractory Prostate Carcinoma: Randomized Phase II Trial With the New, High-Energy Radiopharmaceutical Rhenium-188 Hydroxyethylidenediphosphonate

    Holger Palmedo;Agnieska Manka-Waluch;Peter Albers;Ingo G.H. Schmidt-Wolf

Frequent Co-Authors

Tilman Sauerbruch
Tilman Sauerbruch University of Bonn
Hartmut Goldschmidt
Hartmut Goldschmidt University Hospital Heidelberg
Anna Jauch
Anna Jauch Heidelberg University
Burghardt Wittig
Burghardt Wittig Freie Universität Berlin
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Christian P. Strassburg
Christian P. Strassburg University Hospital Bonn
Anthony D. Ho
Anthony D. Ho University Hospital Heidelberg
Andreas Engert
Andreas Engert University of Cologne
Peter Brossart
Peter Brossart University Hospital Bonn
Hartmut Döhner
Hartmut Döhner University of Ulm

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine can open doors to a range of rewarding online degrees. For those seeking administrative roles in healthcare, online health administration programs offer a fast and flexible route to management positions, even for working professionals.

If you already hold an associate degree in nursing, asn to fnp bridge paths are available online, enabling registered nurses to become Family Nurse Practitioners through streamlined study.

Specialized tracks like the online bachelor's in nutrition provide a focused curriculum for careers in dietetics, wellness, and public health. This pathway is ideal for students passionate about preventive medicine and healthy living.

For those seeking accredited leadership degrees, pursuing online mha programs ensures you're learning within CAHME standards — highly valued across hospitals and healthcare systems.

Online degrees increase accessibility, allowing you to balance study with work or family life. They're a strong choice for individuals mapping diverse career pathways in the healthcare field.

Best Scientists Citing Ingo G.H. Schmidt-Wolf

Trending Scientists

Recently Published Articles